Connetics Corporation (extinct)

Connetics Corporation (extinct)

Connetics Corporation (extinct)

Overview
Date Founded

1993

Headquarters

3160 Porter Drive,Palo Alto, CA 94304-1212

Type of Company

Private

Industries

Biotechnology
Retail: Drug Stores
Wholesale: Consumer Non-Durables/Sundries
Pharmaceuticals

Company Description

Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA.

Contact Data
Trying to get in touch with decision makers at Connetics Corporation? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Paths to Connetics Corporation
Potential Connections via
Relationship Science
You
Connetics Corporation
Recent Transactions
Details Hidden

Stiefel Laboratories, Inc. purchases Connetics Corporation

Details Hidden

Connetics Corporation purchases PediaMed Pharmaceuticals, Inc. /Sales Ops from PediaMed Pharmaceuticals, Inc.

Details Hidden

Connetics Corporation purchases Stiefel Research Australia Pty Ltd. from FH Faulding & Co. Ltd.

Transaction Advisors
Accountant

Advised onConnetics Corporation purchases Stiefel Research Australia Pty Ltd. from FH Faulding & Co. Ltd.

Legal Advisor

Advised onStiefel Laboratories, Inc. purchases Connetics Corporation

Investment Advisor

Advised onStiefel Laboratories, Inc. purchases Connetics Corporation

Attorney

Advised onStiefel Laboratories, Inc. purchases Connetics Corporation

Legal Advisor

Advised onStiefel Laboratories, Inc. purchases Connetics Corporation

Legal Advisor

Advised onStiefel Laboratories, Inc. purchases Connetics Corporation

Advisors & Consultants
Legal Advisor

Partner at Fenwick & West LLP

Legal Advisor

Partner at Fenwick & West LLP

Legal Advisor

Partner at Fenwick & West LLP

Investments
Details Hidden

InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Connetics Corporation. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Connetics Corporation's profile does not indicate a business or promotional relationship of any kind between RelSci and Connetics Corporation.